🇺🇸 Aspirin and indobufen mimetic in United States

Aspirin and indobufen mimetic (Aspirin and indobufen mimetic) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Aspirin and indobufen mimetic in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Aspirin and indobufen mimetic approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Aspirin and indobufen mimetic in United States?

Beijing Anzhen Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.